Table 4 (abstract O16). ACR responses achieved in the cohort by time point
From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
Time point | CAN | ||
|---|---|---|---|
N = 123 | |||
Minimum adapted ACR pediatric response | n (n/m%) | Patients with inactive disease (n/m)% | |
Month 12 | m | 85 | (52/88) 59.1 |
Non-Responders | 4 (4.7) | ||
aACR ≥30 | 81 (95.3) | ||
aACR ≥50 | 77 (90.6) | ||
aACR ≥70 | 73 (85.9) | ||
aACR 100 | 49 (57.6) | ||
Month 21 | m | 65 | (48/65) 73.8 |
Non-Responders | 3 (4.6) | ||
aACR ≥30 | 62 (95.4) | ||
aACR ≥50 | 58 (89.2) | ||
aACR ≥70 | 54 (83.1) | ||
aACR 100 | 39 (60.0) | ||
Last assessment | m | 121 | (62/122) 50.8 |
Non-Responders | 28 (23.1) | ||
aACR ≥30 | 93 (76.9) | ||
aACR ≥50 | 89 (73.6) | ||
aACR ≥70 | 81 (66.9) | ||
aACR 100 | 62 (51.2) | ||